New York – December 1, 2025 –IIRR is pleased to announce the election of Sipika Singh to its Board of Directors, joining the Board as we enter the new year.
With more than 25 years of leadership experience across global large-scale organizations, Ms. Singh brings deep expertise in healthcare management, and inclusive growth. She is Deputy Chief Executive Officer of Gleneagles Hospital Johor premier tertiary hospital under the IHH Healthcare Group. As a part of her role, she provides strategic leadership for over 1200 staff across the hospital’s operations and growth initiatives. Prior to this, she held senior positions at Johnson & Johnson, Novartis, and Arthur Andersen.
“We are honored to welcome Sipika to our Board,” said Emily Cheng, Chair of IIRR. “With her extensive experience across Africa and Asia, and as a senior healthcare executive in one of the region’s leading medical networks, she brings strategic insight and global perspective. We look forward to her contributions across all areas of our work.”
Ms. Singh shared: “It is a privilege to join IIRR as a member of the Board of Directors. My professional life in large healthcare organisations and my personal connection to Africa and India shaped my belief in inclusive, community-centred development. I look forward to supporting IIRR with both my healthcare experience and my passion for creating resilient, equitable solutions for the communities that need them most.
Peter Williams, President of IIRR, added: “Sipika’s appointment reflects our commitment to strengthening IIRR’s global leadership as we expand our work in climate resilience, food security and rural health systems.
IIRR is a global non-profit dedicated to building the resilience and self-reliance of rural communities through regenerative agriculture, sustainable livelihoods, and community-led development. The addition of Ms. Singh strengthens the Board’s capacity to steer IIRR’s expanding global strategy and deepen its impact across Africa and Asia.
